Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

BACKGROUND: Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited. We assessed the risk of adverse perinatal outcomes and major congenital anomalies associated with the use of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Duong Thuy, Preen, David B., Einarsdottir, Kristjana, Kemp-Casey, Anna, Randall, Deborah, Jorm, Louisa R., Choi, Stephanie K. Y., Havard, Alys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001233/
https://www.ncbi.nlm.nih.gov/pubmed/32019533
http://dx.doi.org/10.1186/s12916-019-1472-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001233/
https://www.ncbi.nlm.nih.gov/pubmed/32019533
http://dx.doi.org/10.1186/s12916-019-1472-9

Ejemplares similares